N.B./t/=D Where D is the arithmatic mean of paired differences (before and after treatment)

Biochemical :
Serum bilirubin AET & AST

Observations :
The age and sex incidence of the cases selected are shown in Table 1 clinical investigations in Table 2 and biochemical investigation in Table 3.

Discussion :
Clinically the patients treated with trial drug exhibited a satisfactory response. From Table 2 it can be observed that the symptoms anorexia, abdominal discomfort, lethargy, nausea and jaundice disappeared within a week of treatment with KAMILARI. Liver enlargement however persisted in 12% cases. In the untreated group B however nearly 30 % patients still showed clinical symptoms of viral hepatitis after 2 weeks. As recorded in Table 3. the "t" test showed significant reduction in the serum reduction in the serum bilirubin. ALT & AST values within 7 days of treatment itself compared to the untreated group.

Conclusion :
The result in the present study therefore indicate that KAMILARI could be a valuable therapy for patients suffering from viral hepatitis.

References :
Shirwaikar Annie, Vasanth Kumar A, Krishnanand BR,
Sreenivasan K.K, Indian Drugs, 1991.29.5
Shirwaikar Annie, Vasanth Kumar A, Krishnanand BR,
Sreenivasan K.K, Int J Pharmacognosy 1996
33.(4)305-310
Kioso Y, Suzuki Y, Watanabe N.Oshima Y. Hikkino,
11 Planta Med, 1984, 50.238
Rege. N. Dahanukar.S. Karandikar S.M.
Indian Drugs 1984,21,544-545

Pandu rogi thu yoathyartham pithalani nishevathe I
Thasya pithamasrigmamsam dagdvarogaya kalpathe II
- Charakasamhita (400 A.D)
In such patients of panduroga, who inzdulge in foods and habits which increase pitha, the pitha getting increased burns up the rakta and mamsa and produces the disease.